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The brucellae are the etiological agents of brucellosis, a worldwide-distributed zoonosis. These bacteria are facultative intracel-
lular parasites and thus are able to adjust their metabolism to the extra- and intracellular environments encountered during an
infectious cycle. However, this aspect of Brucella biology is imperfectly understood, and the nutrients available in the intracellu-
lar niche are unknown. Here, we investigated the central pathways of C metabolism used by Brucella abortus by deleting the pu-
tative fructose-1,6-bisphosphatase (fbp and glpX), phosphoenolpyruvate carboxykinase (pckA), pyruvate phosphate dikinase
(ppdK), andmalic enzyme (mae) genes. In gluconeogenic but not in rich media, growth ofppdK andmaemutants was se-
verely impaired and growth of the doublefbp-glpXmutant was reduced. In macrophages, only theppdK andmaemutants
showed reducedmultiplication, and studies with theppdKmutant confirmed that it reached the replicative niche. Similarly,
only theppdK andmaemutants were attenuated in mice, the former being cleared by week 10 and the latter persisting longer
than 12 weeks. We also investigated the glyoxylate cycle. Although aceA (isocitrate lyase) promoter activity was enhanced in rich
medium, aceA disruption had no effect in vitro or on multiplication in macrophages or mouse spleens. The results suggest that
B. abortus grows intracellularly using a limited supply of 6-C (and 5-C) sugars that is compensated by glutamate and possibly
other amino acids entering the Krebs cycle without a critical role of the glyoxylate shunt.
Brucella is a genus of Gram-negative bacteria that includes thecausative agents of brucellosis, a worldwide-extended zoono-
sis severely affecting animal production and human welfare.
Three species, Brucella abortus, B. melitensis, and B. suis, are the
most common causes of brucellosis in domestic livestock and hu-
mans. These brucellae can grow both in vitro and within host cells,
and their pathogenicity results largely from their capacity to es-
cape prompt detection by innate immunity and the use of a type
IV secretion system to reach the replicative niche, an endoplasmic
reticulum-derived vacuole (1–6). In this compartment, these bac-
teria multiply extensively, which shows their ability to efficiently
use substrates provided by the host. However, there is only sparse
information on either the nature of these substrates or the meta-
bolic pathways used in the replicative niche (7).
In vitro, most strains of B. abortus, B. melitensis, and B. suis
grow in several simple chemically defined media (8). Among
these, Gerhardt’s medium contains glycerol, lactate, glutamate,
and mineral salts plus nicotinic acid, thiamine, pantothenic acid,
and biotin as growth factors. This medium supports growth better
than other simple defined media, including those that provide
glucose as the C source (8), and this has been attributed to the
ability of these bacteria to use glutamate very efficiently through
the tricarboxylic acid (TCA) cycle (9). Indeed, growth in this me-
dium is clear proof of the ability of these bacteria to carry out
gluconeogenesis in vitro. Concerning the catabolism of glucose, it
has been accepted that it proceeds through the pentose phosphate
pathway (in conjunction with TCA), rather than through the gly-
colysis or Entner-Doudoroff pathway (Fig. 1). This view, although
supported by early radiorespirometric and enzymatic studies (10,
11) performed with the attenuated B. abortus S19 vaccine, is not
consistent with the presence of the genes putatively encoding all
the enzymes of the Entner-Doudoroff pathway (12). It is possible
that the multiple defects in S19 (13) and/or the experimental con-
ditions in those early experiments precluded detection of key en-
zymes of the Entner-Doudoroff pathway (12).
Concerning intracellular metabolism, some data come from
randomly obtained mutants that show attenuation in human or
mouse macrophages or in HeLa cells. Genes (and their putative
functions) identified in this manner include, in B. suis 1330, a
gguA homologue (gluP, presumably involved in sugar uptake),
some erythritol catabolism genes, gnd (6-phosphogluconate de-
hydrogenase, required for using glucose through the pentose
phosphate pathway), rbsK (ribose kinase), pyc (anaplerotic pyru-
vate carboxylase), pgi (phosphoglucose isomerase), and genes re-
lated to the biosynthesis of amino acids (14–16); in B. melitensis
16M, dbsA and ugpA (ribose and glycerol-3-phosphate transport-
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ers, respectively), glpD (glycerol-3-phosphate dehydrogenase),
and some erythritol catabolism genes (17, 18); and in B. abortus
2308, gluP (previously shown to encode an active glucose and
galactose transporter in this species [19]), gnd (6-phosphoglu-
conate dehydrogenase), gltD (glutamate synthase), and gcvB (gly-
cine dehydrogenase) (20). Also in B. abortus 2308, dxs (an iso-
prenoid biosynthesis transketolase) and mocC (rhizopine or
inositol catabolism) were identified as expressed in macrophages
using a fluorescent reporter (21).
Proteomic analyses have also provided clues to the metabolism
of brucellae in the host. Al Dahouk et al. (22) found that forty-
eight hours after infection of mouse macrophages with B. suis
1330, there was an important reduction of proteins putatively
involved in energy, protein, and nucleic acid metabolism. Some
exceptions were ribitol kinase, glyceraldehyde-3-phosphate-
dehydrogenase (glyceraldehyde-3-P-dehydrogenase), and the
isocitrate lyase (AceA) of the glyoxylate cycle. However, other
studies inB. suis 1330 do not support the use of the glyoxylate cycle
within host cells (15). Lamontagne et al. (23) analyzed B. abortus
2308 protein expression 3, 20, and 44 h after infection of RAW
264.7 macrophages. They found that multiple proteins associated
with sugar uptake, the TCA cycle, the pentose phosphate shunt,
and the subsequent generation of pyruvate were downregulated 3
h after infection. At 24 h, several proteins involved in sugar me-
tabolism and transport were also reduced. Enzymes associated
with protein and amino acid catabolism were mainly increased
early (3 h) but also 24 h after infection, when bacteria were already
in vacuoles derived from the endoplasmic reticulum. This was also
the case for enzymes involved in glutamate synthesis, suggesting
conversion of amino acids to glutamate and -ketoglutarate. Ac-
cordingly, amino acid-based alternatives may be the preferred so-
lution for B. abortus to derive precursors for the TCA cycle and
ancillary routes during the midpoint time course of infection. At
later times, the same authors observed an increase in proteins
involved in transport, suggesting that the endoplasmic reticulum
is able to supply at least some of the substrates required for bacte-
rial growth. Likewise, the pentose phosphate shunt seemed to par-
tially resume its functions.
Although the information provided by these studies is valu-
able, the central metabolic pathways used by Brucella during in-
fection remain unclear. The results are contradictory in some
cases, as for the glyoxylate cycle or the metabolic activity in cells. In
addition, some studies suggest the availability of sugars in the
replicative niche, whereas others indicate that amino acids could
be the preferred C source in vivo, which may require a gluconeo-
genic metabolism. Indeed, apparently conflicting data may result
from the use of different host cell lines, different times of analysis,
polarity of mutations, and other experimental conditions. More-
over, there might be some variation among B. suis 1330, B.
melitensis 16M, and B. abortus 2308, as suggested by the known
differences in oxidative rates of sugars and amino acids (24). In
this work, we attempt to address some aspects of the central met-
abolic pathways used by B. abortus in the host. For this purpose,
we focused our research on genes putatively involved in classical
gluconeogenesis, the anabolic pathways bridging the TCA cycle
and the triose-phosphate pathway, and the glyoxylate cycle. We
constructed in-frame mutations in genes coding for key enzymes
and tested the mutants in complex and chemically defined media
and for multiplication within cultured cells and for persistence in
the mouse model (25). Together with some of the previous anal-
FIG 1 Conventional central metabolic pathways (glycolysis, gluconeogenesis,
Entner-Doudoroff, pentose-phosphate, TCA cycle, and glyoxylate) of bacteria.
Dashed arrows indicate steps for which no putative genes can be identified in B.
abortus. Red arrows indicate the steps studied in this work. AcCoA, acetyl-
CoA; AceA, isocitrate lyase; AceB, malate synthase; Acn, aconitate hydratase;
AKG, -ketoglutarate; Akgdh, -ketoglutarate dehydrogenase; Cgs, cyclic-
glucan synthesis; CIT, citrate; DHAP, dihydroxyacetone phosphate; Eda,
keto-deoxy-phosphogluconate aldolase; Edd, 6-phospho-D-gluconate dehy-
dratase; E4P, erythrose-4-phosphate; Fba, fructose bisphosphate aldolase;
Fbp, fructose-1,6-bisphosphatase; Fum, fumarase; FUM, fumarate; F1,6dP,
fructose-1,6-bisphosphate; F6P, fructose-6-phosphate; GalE, UPD-glucose-4
epimerase; GAP, glyceraldehyde-3-phosphate; Gnd, 6-phosphogluconate de-
hydrogenase; Glk, glucokinase; GlpX, fructose-1,6-bisphosphatase; GltA, ci-
trate synthase; GLX, glyoxylate; G1P, glucose-1-phosphate; G6P, glucose-6-
phosphate; ICIT, isocitrate; Idh, isocitrate dehydrogenase; KDPG, 2-keto-3-
deoxyphosphogluconate; LPS, lipopolysaccharide; Mae, malic enzyme; MAL,
malate; Mdh, malate dehydrogenase; OAA, oxaloacetate; Oad, oxaloacetate
decarboxylase; Pfk, phosphofructokinase; PckA, phosphoenol pyruvate car-
boxykinase; Pdh, pyruvate dehydrogenase; PEP, phosphoenol pyruvate; Pgi,
phosphoglucose isomerase; Pgl, lactonase; Pgm, phosphoglucomutase; Ppc,
phosphoenol pyruvate carboxylase; PpdK, pyruvate phosphate dikinase; Pps,
phosphoenol pyruvate synthase; Pyc, pyruvate carboxylase; Pyk, pyruvate ki-
nase; PYR, pyruvate; RIB5P, ribulose-5-phosphate; Sdh, succinate dehydroge-
nase; Stk, succinyl-CoA synthetase; SUC, succinate; SucCoA, succinyl-CoA;
Tkt, transketolase; TpiA, triose phosphate isomerase; X5P, xylulose-5-phos-
phate; Zwf, glucose-6-phosphate dehydrogenase; 6PG, 6-phosphogluconate;
6PGL, 6-phosphogluconolactone.
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yses, our observations suggest a model ofB. abortusmetabolism in
which, although TCA supplies molecules necessary for biosynthe-
sis and subsequent growth, the classical fructose-1,6-bisphospha-
tases Fbp and GlpX are not necessary and 6- and/or 5-C molecules
for polymer biosynthesis are obtained mostly from the intracellu-
lar milieu.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plas-
mids used in this study are listed in Table S1 in the supplemental material,
and their origin and characteristics are described in previous works (26–
28). The strains resulting from the genetic manipulations described below
were characterized according to standard Brucella typing procedures, i.e.,
colonial morphology after 3 days of incubation at 37°C, crystal violet-
oxalate exclusion, urease, acriflavine agglutination, sensitivity to Tb, Wb,
Iz, and R/C phages, agglutination with anti-A and anti-M monospecific
sera, CO2 and serum dependence, and susceptibility to thionin blue, fuch-
sin, and safranin (24). Bacteria were routinely grown in standard peptone-
yeast extract-glucose broth (bioMérieux) or in this medium supple-
mented with agar (TSA). The following antibiotics were used at the
indicated concentrations: kanamycin (Km; 50g/ml), nalidixic acid (Nal;
25 g/ml), chloramphenicol (Cm; 20 g/ml) and/or gentamicin (Gm;
100 g/ml or 25 g/ml) (all from Sigma). When needed, medium was
supplemented with 5% sucrose (Sigma). All strains were stored at80°C
in skim milk (Scharlau). To study the phenotype of the metabolic mu-
tants, peptone-yeast extract-glucose or the medium of Gerhardt and Wil-
son (referred to here as glutamate-lactate-glycerol) was used (29). The
components (for 1 liter) of the latter were glycerol (30 g), lactic acid (5 g),
glutamic acid (5 g), thiamine (0.2 mg), nicotinic acid (0.2 mg), panto-
thenic acid (0.04 mg), biotin (0.0001 mg), K2HPO4 (10 g), Na2S2O3 ·
5H2O (0.1 g), MgSO4 (10 mg), MnSO4 (0.1 mg), FeSO4 (0.1 mg), and
NaCl (7.5 g). The pH was adjusted to 6.8 to 7.
Growth measurements. Inocula preconditioned to the conditions in
the test medium (peptone-yeast extract-glucose, glutamate-lactate-glyc-
erol, glycerol-glutamate, glycerol-lactate, or glutamate-lactate) were pre-
pared as follows. First, the strains to be tested were inoculated into 10 ml
of peptone-yeast extract-glucose in a 50-ml flask and incubated at 37°C
with orbital shaking for 18 h. These exponentially growing bacteria were
harvested by centrifugation, resuspended in 5 ml of the test medium at an
optical density at 600 nm (OD600) of 0.1, and incubated at 37°C with
orbital shaking for 18 h. Then, these preconditioned bacteria were har-
vested by centrifugation, resuspended at an OD600 of 0.1 (0.05 starting in
the Bioscreen apparatus) in the same test medium in Bioscreen multiwell
plates (200 l/well), and cultivated in a Bioscreen C (Lab Systems) appa-
ratus with continuous shaking at 37°C. Absorbance values at 420 to 580
nm were automatically recorded at 0.5-h intervals over a 120- to 300-h
period. All experiments were performed in triplicate. Controls with cul-
ture medium and no bacteria were included in all experiments.
DNA manipulations. Genomic sequences were obtained from the
Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http:
//www.genome.jp/kegg/). Searches for DNA and protein homologies
were carried out using the National Center for Biotechnology Informa-
tion (NCBI; http://www.ncbi.nlm.nih.gov/) and the European Molecular
Biology Laboratory (EMBL)–European Bioinformatics Institute server
(http://www.ebi.ac.uk/). Primers were synthesized by Sigma-Genosys
(Haverhill, United Kingdom). DNA sequencing was performed by the
Servicio de Secuenciación del Centro de Investigación Médica Aplicada
(Pamplona, Spain). Restriction-modification enzymes were used under
the conditions recommended by the manufacturer. Plasmid and chromo-
somal DNA were extracted with QIAprep spin miniprep (Qiagen) and
Ultraclean microbial DNA isolation kits (Mo Bio Laboratories), respec-
tively. When needed, DNA was purified from agarose gels using the
QIAquick gel extraction kit (Qiagen).
In-frame fbp and glpX deletion mutants were constructed by PCR
overlap using genomic DNA of B. abortus 2308 as the DNA template.
Primers were designed using the B. abortus 2308 sequences available in
KEGG (http://www.genome.jp/kegg/). For the construction of the fbp
mutant, two PCR fragments were generated: oligonucleotides fbp-F1(5=-
GTAGCCAAAAAGCCCAGGT-3=) and fbp-R2 (5=-GCCAACCAGAACC
AGAGGA-3=) were used to amplify a 203-bp fragment including codons 1
to 14 of the fbp open reading frame (ORF) as well as a 161-bp fragment
upstream of the fbp start codon, and oligonucleotides fbp-F3 (5=-TCCTC
TGGTTCTGGTTGGCGTGGCCGAAGAGGTGGATA-3=) and fbp-R4
(5=-CATTTGCCGCTTCCATGA-3=) were used to amplify a 193-bp frag-
ment including codons 327 to 341 of the fbp ORF and a 148-bp fragment
downstream of the fbp stop codon. Both fragments were ligated by PCR
using oligonucleotides fbp-F1 and fbp-R4 for amplification and the com-
plementary regions between fbp-R2 and fbp-F3 for overlapping. The re-
sulting fragment, containing the fbp deletion allele, was cloned into
pCR2.1 (Invitrogen) to generate plasmid pAZI-1, sequenced to ensure
that the reading frame was maintained, and subcloned into the BamHI
and the XbaI sites of the suicide plasmid pJQKm (30). The resulting mu-
tator plasmid (pAZI-2) was introduced into B. abortus 2308 by conjuga-
tion (26). Integration of the suicide vector was selected by Nal and Km
resistance, and the excisions (generating both the fbp mutant [BABfbp]
and a sibling revertant strain carrying an intact gene [BABfbp-sibling re-
vertant]) were then selected by Nal and sucrose resistance and Km sensi-
tivity. The resulting colonies were screened by PCR with primers fbp-F1
and fbp-R4, which amplified a fragment of 396 bp in the mutant and a
fragment of 1,332 bp in the sibling revertant strain. The mutation resulted
in the loss of about 98% of the fbp ORF, and the mutant strain was called
BABfbp.
The glpX mutant was constructed in a similar way. Primers glpX-F1
(5=-ACGGTGATTCTGGTGACACA-3=) and glpX-R2 (5=-CGAGCTCCA
GTGTGAGAATG-3=) were used to amplify a 576-bp fragment including
61 bp of the glpX ORF as well as 515 bp upstream of the glpX start codon,
and primers glpX-F3 (5=-CATTCTCACACTGGAGCTCGATACGACAG
ATCCGGACGAG-3=) and glpX-R4 (5=-CATCATACAGTTGCCGATG
G-3=) were used to amplify a 574-bp fragment including 371 bp of the glpX
ORF and 203 bp downstream of the glpX stop codon. Both fragments were
ligated by overlapping PCR using primers glpX-F1 and glpX-R4, and the
fragment containing the deletion allele was cloned into pCR2.1 to gener-
ate plasmid pAZI-3, sequenced to confirm that the glpX ORF had been
maintained, and subcloned in pJQKm to produce the mutator plasmid
pAZI-4. This plasmid was then introduced into B. abortus 2308, and the
deletion mutant generated by allelic exchange was selected by Nal and
sucrose resistance and Km sensitivity and by PCR using oligonucleotides
glpX-F1 and glpX-R4, which amplified a fragment of 1,150 bp in the dele-
tion strain and a fragment of 1,705 bp in the BABglpX-sibling revertant
strain. The mutation resulted in the loss of approximately 56% of the glpX
ORF, and the mutant was called BABglpX.
To construct the double mutant BABfbpglpX, the mutator plasmid
pAZI-4 was introduced into strain BABfbp. After allelic exchange, the
double mutant was selected as described above using primers glpX-F1 and
glpX-R4.
BABaceA was constructed using the same strategy. Oligonucleotides
aceA-F1 (5=-TGACAAGATATCGCCAAAACAC-3=) and aceA-R2 (5=-C
GAAGGGATGAGGCTGTAAA-3=) amplified a 238-bp fragment, includ-
ing codons 1 to 10 of the aceA ORF and 208 bp upstream of the aceA start
codon. Oligonucleotides aceA-F3 (5=-TTTACAGCCTCATCCCTTCGG
AAACCGCACAGTTCAAGC-3=) and aceA-R4 (5=-GGATCAAGAGATC
ACCCCAGT-3=) amplified a 278-bp fragment including codons 420 to
430 of the ORF aceA and 245 bp downstream of the aceA stop codon. Both
fragments were ligated by overlapping PCR using oligonucleotides
aceA-F1 and aceA-R4. The PCR product was cloned into pCR2.1 to gen-
erate pAZI-7, sequenced, and subcloned into pJQKm to produce the sui-
cide plasmid pAZI-8. B. abortus 2308 mutants were selected by PCR using
oligonucleotides aceA-F1 and aceA-R4. PCR products were 1,743 bp in the
BABaceA-sibling revertant strain and 738 bp inBABaceA. This mutation
eliminated 78% of the aceA ORF.
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For the construction of the pckA mutant, oligonucleotides pckA-F1
(5=-TGTTTGCAGTTTTCCACACC-3=), pckA-R2 (5=-AATCGAAGCGG
CCTTATTGT-3=), pckA-F3 (5=-ACAATAAGGCCGCTTCGATTGACG
GCTCGCTGAACAAT-3=), and pckA-R4 (5=-TCTTGCGATAACAGCCA
AAA-3=) were used. Primers pckA-F1 and pckA-R2 amplified a 219-bp
fragment which included codons 1 to 13 of the pckA ORF and 180 bp
upstream of the pckA start codon. Primers pckA-F3 and pckA-R4 ampli-
fied a 319-bp fragment including the last 37 codons of the pckA ORF and
208 bp downstream of the pckA stop codon. Both PCR products were
ligated by overlapping PCR using pckA-F1 and pckA-R4, cloned into
pCR2.1 to generate plasmid pAZI-5, and subsequently subcloned into the
BamHI and the XbaI sites of the suicide plasmid pJQKm. The resulting
mutator plasmid, pAZI-6, was introduced into B. abortus 2308, where it
was integrated into the chromosome. A second recombination generated
the excision of the plasmid. The resulting colonies were screened by PCR
(with pckA-F1 and pckA-R4) amplifying a fragment of 538 bp in the mu-
tant and a fragment of 1,864 bp in the sibling revertant strain. The mutant
strain was called BABpckA and lacked the 71.14% of the pckA ORF.
BABppdK was constructed using primers ppdK-F1(5=-CTCCCGAT
TCATTTTTCACG-3=) and ppdK-R2 (5=-TGCTCATTTCAGCCAGGTT-
3=) to amplify a 288-bp fragment including the first 103 bp of the ppdK
ORF as well as 185 bp upstream of the ppdK start codon and primers
ppdK-F3 (5=-AACCTGGCTGAAATGAGCACGGGTCTCGACTATGTG
TCC-3=) and ppdK-R4 (5=-TCAACGCATCAAAGCAGAAG-3=) to am-
plify a 220-bp fragment including the last 86 bp of the ppdK ORF and 134
bp downstream of the ppdK stop codon. Both fragments were ligated by
overlapping PCR using primers ppdK-F1 and ppdK-R4, and the fragment
obtained, containing the deletion allele, was cloned into pCR2.1 to gen-
erate pMZI-1, sequenced to confirm that the reading frame had been
maintained, and subcloned into pJQKm to produce the mutator plasmid
pMZI-2. This plasmid was introduced into B. abortus 2308, and both the
deletion mutant and the sibling revertant strain generated by allelic ex-
change were selected by Nal and sucrose resistance and Km sensitivity and
by PCR using ppdK-F1 and ppdK-R4, which amplified a fragment of 508
bp in BABppdK and a fragment of 2,983 bp in BABppdK-sibling rever-
tant strain. The mutation generated resulted in the loss of the 93% of
ppdK.
Primers ppdKII-F1 (5=-CTCCCGATTCATTTTTCACG-3=), ppd-
KII-R2 (5=-CTGCTCATTTCAGCCAGGTT-3=), ppdKII-F3 (5=-AACCT
GGCTGAAATGAGCAGCGGGTCTCGACTATGTGTCC-3=), and ppd-
KII-R4 (5=-TCAACGCATCAAAGCAGAAG-3=) were used to obtain the
mutator plasmid pAZI-10. This plasmid was introduced into B. abortus
2308 to obtain a ppdK mutant that maintained only the 34 first amino
acids of PpdK (BABppdK-II). This mutant had the same phenotype as
the one previously described. Thus, the mutator plasmid pAZI-10 was
also introduced into strain BABpckA carrying the pckA mutation to ob-
tain the double mutant BABpckAppdK.
BABmae was constructed using primers mae-F1 (5=-TATGACGGC
GCACTTGTCTA-3=) and mae-R2 (5=-TCGGATAGCGATGGAAGAAC-
3=) to amplify a 341-bp fragment including 76 bp of the mae ORF as well
as 265 bp upstream of the mae start codon, and primers mae-F3 (5=-GTT
CTTCCATCGCTATCCGAGCGAAGCCAATCTTCTGGTA-3=) and mae-R4
(5=-CGCCATAAAACGAACCTCAA-3=) to amplify a 376 bp including
227 bp of the mae ORF and 149 bp downstream of the mae stop codon.
Both fragments were ligated by overlapping PCR using primers mae-F1
and mae-R4, and the fragment obtained, containing the deletion allele,
was cloned into pCR2.1 to generate pMZI-3, sequenced to confirm that
the mae ORF had been maintained, and subcloned into pJQKm to pro-
duce the mutator plasmid pMZI-4. This plasmid was then introduced into
B. abortus 2308, and the mutant and sibling revertant strains generated by
allelic exchange were selected by Nal and sucrose resistance and Km sen-
sitivity and by PCR using oligonucleotides mae-F1 and mae-R4, which
amplified a fragment of 717 bp in the deleted strain and a fragment of
2,739 bp in the sibling revertant strain. The mutation generated resulted
in the loss of the 87% of the mae ORF.
To check the different mutations, we used internal primers (gene-R5)
hybridizing in the deleted regions.
For complementation, a plasmid carrying ppdKwas constructed using
the Gateway cloning Technology (Invitrogen). Since the sequences of
ppdK from B. abortus and B. melitensis are 99% identical, the clone carry-
ing ppdKwas extracted from the B.melitensisORFeome, and the ORF was
subcloned into plasmid pRH001 (31) to produce plasmid pAZI-19. This
plasmid was introduced into BABppdK by mating with Escherichia coli
S17 pir, and the conjugants harboring this plasmid (designated
BABppdK pAZI-19) were selected by plating the mating mixture onto
tryptic soy agar (TSA) plates containing Nal and Km (TSA-NalKm). For
the construction of BABfbpglpX pAZI-21, fbp was amplified from
BAB-parental using primers fbp-Fp (5=-GGGATCCATGCTTCTGAAAG
GGTGGTACCG-3=) and fbp-R4 (5=-CATTTGCCGCTTCCATGA-3=)
and cloned into pCR2.1. The resulting plasmid was sequenced, and the fbp
gene was subcloned into the BamHI and the XhoI sites of the vector
pBBR1MCS1. The resulting plasmid (pAZI-21) was introduced into
BABfbpglpX by conjugation (see above). BABfbpglpX(pAZI-23)
was constructed by following the same strategy and using primers glpX-F1
(5=-ACGGTGATTCTGGTGACACA-3=) and glpX-R4 (5=-CATCATACA
GTTGCCGATGG-3=) to amplify glpX.
Gene expression studies. To determine whether aceA was expressed
in vitro, its promoter was fused with the luciferase reporter gene. To this
end, aceAp-F (5=-GGGATCCTAGTTGCGCTCGATCAGATT-3=) and
aceAp-R (5=-TTCTAGACATTTCGGTGTCTCCTCGT-3=) (containing
BamHI and XbaI sites [underlined], respectively) were used to amplify a
382-bp region containing the ATG and the aceA promoter fromB. abortus
2308 genomic DNA. This PCR product was verified by electrophoresis
and ligated into the vector pGEM-T Easy (Promega), thereby originating
plasmid pAZI-17. Then, the insert was digested with BamHI and XbaI and
ligated to pSKOriTKmluxAB to generate plasmid pAZI-18. This plasmid
was introduced into E. coli S17 pir Nals and then transferred by conju-
gation to B. abortus 2308 Nalr Kms. Cells were plated on TSA-NalKm.
Positive clones gave a 510-bp band when verified by PCR using aceAp-F
and luxAB-R. The resulting strain was called B. abortus pBABaceA-luxAB.
To measure luciferase activity, fresh B. abortus pBABaceA-luxAB cells
were adjusted to an OD600 of 0.4 in saline, and finally, 50 or 200 l was
added to flasks with 10 ml of peptone-yeast extract-glucose or glutamate-
lactate-glycerol, respectively. Growth was followed by measuring absor-
bance at OD600, and 1-ml aliquots were taken at selected intervals to
measure the luminescence in relative luminescence units (RLU) after ad-
dition of 100 l ethanol-decanal (1:1).
Cell infections and intracellular trafficking. In vitro infection assays
were performed in RAW 264.7 macrophages (ATCC TIB-71) and HeLa
cells (ATCC CCL-2) cultured in Dulbecco’s modified Eagle medium
(DMEM; Gibco) with 10% (vol/vol) heat-inactivated fetal bovine serum
(Gibco), 1% (vol/vol) L-glutamine (200 nM; Sigma-Aldrich), and 1%
(vol/vol) nonessential amino acids (Gibco). Then, 24-well plates were
seeded with 1  105 cells/well, and macrophages and HeLa cells were
infected at multiplicities of infection of 50:1 and 200:1 (bacteria to cells),
respectively, by centrifuging the plates at 400 g for 10 min at 4°C. After
incubation for 15 min at 37°C under a 5% CO2 atmosphere, extracellular
bacteria were removed with four DMEM washes followed by Gm treat-
ment (100g/ml) for 90 min. Then, fresh medium supplemented with 25
g/ml of Gm was added and cultures were incubated. At 2, 24, and 48 h,
cells were washed three times with 100 mM phosphate-buffered saline
(pH 7.2), lysed with 0.1% (vol/vol) Triton X-100 in phosphate-buffered
saline, and plated on TSA to determine the number of intracellular bac-
teria. All experiments were performed in triplicate (32). Results were ex-
pressed as means and standard errors (n  3) of individual log10 CFU/
well. Statistical comparison of means was performed by a one-way
analysis of variance (ANOVA) followed by Fisher’s protected least signif-
icant differences (PLSD) tests (33).
For immunofluorescence microscopy, RAW 264.7 macrophages and
HeLa cells were grown on coverslips and inoculated with bacteria as de-
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scribed above. Cells were fixed in 3% paraformaldehyde in 100 mM phos-
phate-buffered saline (pH 7.2) at 37°C for 10 min. Cells were washed twice
with phosphate-buffered saline and permeabilized with 0.1% (vol/vol)
Triton X-100 and 3% bovine serum albumin (Sigma), for 30 min. Cover-
slips were incubated with primary antibodies for 45 min at room temper-
ature, washed three times in the same phosphate-buffered saline supple-
mented with 3% bovine serum albumin, and then incubated with the
appropriate secondary antibodies. Coverslips were washed three times
with phosphate-buffered saline and once with H2O and mounted on glass
slides using Mowiol 4-88. Samples were examined and images acquired
using a Leica TCS SP5 laser scanning confocal microscope at UNAmur
(Namur, Belgium). The primary antibodies used for immunofluores-
cence microscopy were rabbit anti-calnexin (SPA-860; Stressgen) and a
mouse anti-S-LPS monoclonal antibody (A76/12G12/F12). The second-
ary antibodies were donkey anti-rabbit IgG conjugated to Alexa Fluor 488
(Invitrogen) and goat anti-mouse IgG conjugated to Alexa Fluor 546 (In-
vitrogen). For lysosomal labeling, the primary antibody used was rat anti-
mouse (Developmental Studies Hybridoma Bank [DSHB]), and the sec-
ondary antibody was goat anti-rat IgG conjugated to Alexa Fluor 633
(Invitrogen).
Assays in mice. Female BALB/c mice (Charles River, France) were
kept in cages with water and food ad libitum and accommodated under P3
biosafety containment conditions for 2 weeks before and during the ex-
periments in the facilities of the Instituto de Agrobiotecnología (registra-
tion code ES/31-2016-000002-CR-SU-US). The animal handling and
other procedures were in accordance with the current European (directive
86/609/EEC) and Spanish (RD 53/2013) legislations, supervised by the
Animal Welfare Committee of the Universidad Pública de Navarra, and
authorized by the competent authority of Gobierno de Navarra. To pre-
pare inocula, TSA-grown bacteria were harvested, adjusted spectropho-
tometrically (OD600  0.170) in 10 mM phosphate-buffered saline (pH
6.85), and diluted in the same diluent up to approximately 5  105
CFU/ml (exact doses were assessed retrospectively). For each bacterial
strain, five mice were intraperitoneally inoculated with 0.1 ml/mouse, and
the number of CFU in spleen was determined at different weeks postin-
oculation as described previously (33). The identity of the spleen isolates
was confirmed by PCR. The individual number of CFU/spleen was nor-
malized by logarithmic transformation, and the mean log CFU/spleen
values and the standard deviations were calculated for each group of mice
(n  5). Statistical comparisons were performed by a one-way ANOVA
followed by Fisher’s protected least significant differences (PLSD) tests
(33).
RESULTS
Dysfunction of B. abortus fbp, glpX, ppdK, and mae but not of
pckA or aceAhomologues affects growth on gluconeogenic sub-
strates in vitro. The conversion of fructose-1,6-bisphosphate into
fructose-6-P mediated by the cognate bisphosphatases (FBPases)
is the only irreversible step among those taking part in gluconeo-
genesis in Brucella (Fig. 1). Therefore, FBPase activity is strictly
necessary for growth under gluconeogenic conditions.
As in E. coli and Salmonella, the B. abortus 2308 genome
contains two ORFs for putative FBPases: BAB2_0364 and
BAB1_1292. The former is predicted to encode a protein of 340
amino acids that belongs to the class I FBPases (Fbp), and the
latter is predicted to encode a 328-amino-acid protein ortholo-
gous to E. coli GlpX, an FBPase of class II (Fig. 1). In E. coli, Fbp is
connected to the production of fructose-6-phosphate for nucleo-
tide, polysaccharide, and aromatic amino acid biosynthesis. GlpX,
on the other hand, belongs to an operon (glpFKX) related to phos-
pholipid biosynthesis (34). The putative B. abortus glpX, however,
seems isolated and not part of any obvious operon.
We constructed mutants carrying in-frame deletions in the
putative fbp (BABfbpmutant) and glpX (BABglpX) as well as in
both genes (BABfbpglpX) and tested their growth in a complex
(peptone-yeast extract-glucose) medium and in the chemically
defined medium of Gerhardt and Wilson (glutamate-lactate-glyc-
erol). In the complex medium, the three mutants grew with gen-
eration times and final yields similar to those of B. abortus 2308
(BAB-parental) (Fig. 2A.1). BAB-parental showed reduced
growth rates and final yields in glutamate-lactate-glycerol, as ex-
pected, and we obtained identical results with BABfbp and
BABglpX (Fig. 2A.2). On the other hand, BABfbpglpX exhib-
ited a markedly lower increase in turbidity in the minimal me-
dium (Fig. 2A.2). Complementation with plasmid pAZI-21 carry-
ing fbp or with pAZI-23 carrying glpX restored the ability to grow
in glutamate-lactate-glycerol to levels close to that of the parental
strain (see Fig. S3 in the supplemental material). These experi-
ments strongly suggest that B. abortus Fbp and GlpX are func-
tional, an interpretation reinforced by their reciprocal comple-
mentation (i.e., Fbp complemented BABglpX, and conversely,
GlpX complemented BABfbp). We then tested combinations of
two C sources (glycerol-glutamate, glycerol-lactate, and gluta-
mate-lactate). Whereas BABglpX was not affected, BABfbp
showed retarded growth only in the absence of glycerol (i.e., in
glutamate-lactate) (Fig. 3, top). Since GlpX is the FBPase remain-
ing in BABfbp and this mutant grew normally when glycerol was
present, this result suggests that, as inE. coli (34), GlpX is related to
glycerol metabolism. Finally, although retarded and diminished,
the double BABfbpglpX mutant still showed significant growth
(Fig. 3, top).
During these experiments we noticed that BABfbpglpX-in-
oculated broths did not produce homogeneous growth. This was
clearly observed when the double mutant was grown in gluta-
mate-lactate-glycerol in side-arm flasks instead of the automated
Bioscreen system. Under these conditions, the bacteria formed
macroscopic aggregates (Fig. 4), settling on the bottom of the
flasks, which indicated a profound surface modification consis-
tent with an altered biosynthesis of envelope molecules. In sum-
mary, although Fbp and GlpX deficiency did not abrogate bacte-
rial multiplication, these enzymes were required not only for full
growth but also for production of normal cells.
Next, we investigated the pathways that supply pyruvate or
PEP for gluconeogenesis. For this purpose, we carried out a
genomic search for homologues of the genes encoding the en-
zymes connecting the TCA cycle and the triose-phosphate
pathway in bacteria (Fig. 1). We identified homologues of pdh
(pyruvate dehydrogenase), pyk (pyruvate kinase), pckA (phos-
phoenolpyruvate carboxykinase), ppdK (pyruvate-phosphate
dikinase), pyc (pyruvate carboxylase), and mae (malic enzyme)
but not of oad (oxaloacetete decarboxylase), pps (phosphoenolpy-
ruvate synthase), or ppc (phosphoenolpyruvate carboxylase) (Fig.
1). Since Pyc, Pdh, and Pyk catalyze irreversible catabolic steps, we
studied the pckA, ppdK, and mae homologues.
B. abortus 2308 BAB1_2091 is annotated as a pseudogene
in some databases (http://www.genome.jp/kegg/) but not in
others (http://biocyc.org.). This ORF encodes a protein of 491
amino acids that has 77% similarity to the PckA of the phyloge-
netically related Agrobacterium tumefaciens, a protein of 536
amino acids known to be functional (35). However, B. abortus
BAB1_2091 is separated by a stop codon from an intergenic region
that together with BAB1_2090 encodes the last 45 amino acids
present in A. tumefaciens PckA. The frameshift that generates this
stop codon is present also in all B. abortus strains sequenced so far
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(http://www.genome.jp/kegg/). Nevertheless, B. abortus PckA
conserves the IGGTSYAGE-KKS domain (amino acids 190 to 202,
where “-” indicates any amino acid) specifically required for the
carboxykinase activity (36) as well as the phosphate binding site
(G--G-GKT; amino acids 236 to 243) and ATP and metal binding
sites, so that its functionality is not obviously compromised. In
contrast, the putative B. abortus 2308 PpdK (encoded by
BAB1_0525) represents a complete protein of 887 amino acids
with the PEP-binding (amino acids 19 to 376) and the TIM barrel
(amino acids 530 to 883) domains characteristic of PEP-utilizing
enzymes.
To test whether these ORF-encoded enzymes are required for
growth under gluconeogenic conditions, we constructed the non-
polar mutants BABpckA and BABppdK. Moreover, since both
PckA and Ppdk catalyze reactions eventually leading to PEP (Fig.
1), we excluded their reciprocal complementation by constructing
FIG 2 Growth curves in peptone-yeast extract-glucose (A.1, B.1, and C.1) and glutamate-lactate-glycerol (A.2, B.2, and C.2) of BAB-parental and the mutants
BABfbp, BABglpX, BABfbpglpX, BABpckA, BABppdK, BABpckAppdK and BABmae. Each point represents the mean	 standard error (error bars
are within the size of the symbols) of optical density (O.D.) values for triplicate samples. The experiment was repeated three times with similar results.
FIG 3 Growth curves in glycerol-glutamate, glycerol-lactate, and glutamate-lactate of BAB-parental and the mutants BABfbp, BABglpX, BABfbpglpX,
BABppdK, and BABmae. Each point represents the mean for triplicate samples (error bars are within the size of the symbols). The experiment was repeated
three times with similar results.
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the double mutant BABpckAppdK. We then compared the
growth of BAB-parental and the mutants in peptone-yeast ex-
tract-glucose and in glutamate-lactate-glycerol. Whereas we did
not observe differences in the growth of BABpckA and BAB-
parental in these two media, both BABppdK and BAB
pckAppdK had markedly reduced growth in glutamate-lactate-
glycerol (Fig. 2B). Complementation with plasmid pAZI-19
carrying ppdK restored the phenotype (see Fig. S1 in the supple-
mental material), and the sibling revertant control (see Materials
and Methods) conserved the wild-type phenotype (data not
shown). These results strongly suggest that PpdK is functional and
that, consistent with the frameshift in pckA, PckA does not syn-
thesize PEP from oxaloacetate in B. abortus. The possibility that
the role of B. abortus PckA is not detectable under these in vitro
conditions seems less likely.
We followed a similar strategy to study the putative mae.
BAB1_1036 encodes a protein of 774 amino acids annotated as
a NADP (or NAD)-dependent enzyme involved in malate me-
tabolism (http://www.genome.jp/kegg/; http://biocyc.org/).
The N-terminal domain (amino acids 28 to 160) and the NADP
(or NAD)-binding domain (amino acids 172 to 409) characteris-
tic of the malic enzyme are conserved in the BAB1_1036 predicted
protein. MutantBABmae (with a deletion in the region encoding
amino acids 26 to 673) displayed a small reduction in growth in
peptone-yeast extract-glucose and a more marked one in gluta-
mate-lactate-glycerol (Fig. 2C). The impairment was not as accen-
tuated as that of BABppdK (Fig. 2, compare panels B and C). In
these experiments, mae mutants with the above-described pheno-
type were consistently obtained, and the control sibling revertants
with the wild-type phenotype were recovered after the last recom-
bination event (see Materials and Methods; also, see Fig. S2 in the
supplemental material). Taken together, these results support the
hypothesis that B. abortus Mae supplies pyruvate for PpdK to pro-
duce PEP for gluconeogenesis, lactate being a complementary
source of pyruvate in glutamate-lactate-glycerol (Fig. 1). We
tested this hypothesis further by using media containing only two
of the three C substrates of this chemically defined medium.
BABmae did not grow in glycerol-glutamate and showed opti-
mal growth in glycerol-lactate and reduced growth in glutamate-
lactate (Fig. 3, bottom). These results are fully consistent with the
predicted role of Mae (Fig. 1) and suggest that although B. abortus
2308 can use glycerol, glutamate, and lactate, provision of the
latter cannot completely replace the Mae pathway. This interpre-
tation is also supported by the fact that whereas PpdK dysfunction
in BABppdK severely impaired growth in glycerol-lactate and
glutamate-lactate, this mutant grew in glycerol-glutamate (Fig. 3,
bottom), two substrates able to act as sources of PEP and pyruvate
through the triose-P and Mae pathways, respectively (Fig. 1). In-
deed, all these results are in agreement with the early studies that
led to the formulation of the simple medium of Gerhardt and
Wilson as well as with the nutritional studies that showed the
preferential use of glutamate and the complementary role of glyc-
erol and lactate in B. abortus (9). Also, the demonstration by Marr
et al. (37) of the ability of B. abortus to generate pyruvate (and
alanine) from glutamate supports an activity of Mae in this bacte-
rium (Fig. 1).
Since the putative Mae was active in B. abortus 2308, we inves-
tigated whether malate replenishment could occur through the
classical glyoxylate pathway (Fig. 1) or the PEP-glyoxylate cycle.
The latter cycle combines the operation of PckA with the glyoxy-
late cycle enzymes and operates in E. coli under conditions of
glucose limitation (38). In these pathways, isocitrate lyase (AceA)
cleaves isocitrate to yield glyoxylate and succinate, and a malate
synthase (AceB) condenses glyoxylate and acetyl coenzyme A
(acetyl-CoA) to produce malate (39–41). The genome of B. abor-
tus 2308 carries only one putative aceA (ORF BAB1_1631) and one
putative aceB (ORF BAB1_1663). The predicted AceA is a protein
of 429 amino acids with 61% identity and 76% similarity to E. coli
AceA, and it conserves the amino acids required for the enzymatic
activity and the assembly of the tetrameric enzyme (42–47). The
predicted AceB has 728 amino acids with 59% identity and 74%
similarity to E. coli malate synthase G, and it conserves the cata-
lytic site and the amino acids interacting with acetyl-CoA (48, 49).
Accordingly, we constructed a nonpolar BABaceA mutant with
truncations of the 409 central amino acids. This mutant did not
show growth differences relative to BAB-parental in peptone-
yeast extract-glucose and glutamate-lactate-glycerol (data not
shown), even though these media contain acetogenic substrates
(glucose, glycerol, lactate, serine, threonine, and alanine) (50).
Since the genomic analysis strongly suggests the presence of the
glyoxylate cycle, we examined this point further by constructing a
luciferase reporter under the control of the AceA promoter. Al-
though growth curves were similar, luciferase activity was consid-
erably higher in peptone-yeast extract-glucose than in glutamate-
lactate-glycerol (Fig. 5), as would be expected if the glyoxylate
cycle becomes active depending on the abundance of acetogenic
substrates. In such a case, the lack of a change in phenotype in
FIG 4 Immunofluorescence analysis of BAB-parental and BABfbpglpX grown in glycerol-lactate-glutamate. Cells were labeled with anti-smooth-lipopoly-
saccharide mouse monoclonal antibody A76/12G12/F12 and Alexa Fluor 546-conjugated goat anti-mouse immunoglobulin.
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complex media could be explained if the glyoxylate cycle plays
only a subsidiary role in this rich medium, and the experiments do
not rule out the possibility that it becomes important under other
nutritional conditions.
B. abortus strainswithmutations inppdK andmaebutnot in
fbp, glpX, pckA, or aceA show lowermultiplication rates inmac-
rophages. B. abortus is characteristically able to multiply intracel-
lularly in professional phagocytes (51). We thus investigated the
ability of the above-described mutants to multiply in macro-
phages using the parental strain and the attenuated virB mutant
(unable to reach the replicating vacuole) as controls. Figure 6A
shows that BABfbpglpX replicated like BAB-parental, even
though these bacteria differed in growth under gluconeogenic
conditions in vitro (see above). BABppdK (Fig. 6B) and
BABmae (Fig. 6C) multiplied in macrophages, although at lower
overall rates than BAB-parental both 24 h (P
 0,0001) and 48 h
(P
 0,0001) after infection. On the other hand, mutation of pckA
had no effect either by itself or combined with the ppdK deletion
(Fig. 6B).
These results suggest that, albeit impaired in growth,
BABppdK and BABmae are still able to reach the replicative
intracellular niche. Since Mae and PpdK belong to the same path-
way, we selected BABppdK (the mutant blocked in the upper
step of the pathway; Fig. 1) to confirm that the metabolic dysfunc-
tion did not prevent these bacteria from reaching the endoplasmic
reticulum-derived replicating niche. Figure 7A shows that, in con-
trast to the virB mutant, BABppdK and the parental bacteria
were similar in intracellular distribution.
B. abortus can also penetrate and multiply in epithelial cells
(51). We found that the behavior of BABppdK in macrophages
was reproduced in HeLa cells (Fig. 7A and B). In addition, we
found that the numbers of CFU of the mutant and BAB-parental
in HeLa cells did not differ 2 h after infection (data not shown),
indicating that they were similar with regard to penetration.
B. abortus strainswithmutations inppdK andmaebutnot in
pckA, fbp, glpX, or aceA are attenuated inmice. VirulentB. abor-
tus is able to establish spleen infections in mice that characteristi-
cally develop in four phases: (i) onset phase (spleen colonization;
first 48 h); (ii) acute phase (from the third day to weeks 2 to 4),
when bacteria reach maximal numbers; (iii) chronic steady phase
(weeks 2 to 4 to 12), where the bacterial numbers plateau; and (iv)
chronic declining phase, during which brucellae are eliminated.
The ability to induce a marked splenomegaly is also a characteris-
tic of virulent brucellae (25). Using this model, we first studied the
BABfbpglpXmutant and found that it did not differ fromBAB-
parental in either the CFU/spleen profile or the splenomegaly in-
FIG 5 Luciferase expression under the control of B. abortus aceA promoter in peptone-yeast extract-glucose and glutamate-lactate-glycerol. The results are
representative of three experiments (RLU, relative luminescence units).
FIG 6 Intracellular multiplication in RAW 264.7 macrophages of BAB-parental and the mutants BABfbpglpX, BABpckA, BABppdK, BABpckAppdK,
and BABmae (the virB mutant is an attenuated mutant used as a control). Values are means	 standard errors for triplicate infections, and the results shown
are representative of three independent experiments.
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duced (Fig. 8A). Similarly, we did not observe attenuation for
BABpckA (Fig. 8B), which is remarkable because pckA expres-
sion increases in B. abortus with mutations in BvrR/BvrS, a master
regulator of B. abortus virulence (52). Nevertheless, this result is
consistent with the genomic features of pckA and with the above-
described experiments in vitro and in macrophages.
BABppdK failed to reach the chronic steady phase typical of
virulent brucellae, yielding significantly lower CFU counts after
week 2 (Fig. 8B). Clearly indicative of the strong attenuation of
BABppdK, we did not recover any bacteria from the spleens of 3
out of the 5 mice examined at postinfection week 12, and this
mutant induced less splenomegaly than the virulent bacteria (Fig.
8B). Consistent with the observations that showed no additive
effect of the mutations of ppdK and pckA in macrophages or in
vitro, the results for BABpckAppdK in mice paralleled those for
BABppdK (Fig. 8B). BABmae produced a CFU/spleen profile
that differed from those of both BAB-parental and BABppdK.
Although not affected in the first 48 h (onset phase; not shown)
this mutant showed a lower multiplication rate during the acute
phase (Fig. 8C) that was reminiscent of the lower multiplication
rates observed in macrophages. Strikingly, even though CFU/
spleen numbers were lower than those of the wild-type strains,
BABmae produced a chronic steady phase with reduced spleno-
megaly.
Finally, we tested BABaceA in mice. In a first experiment,
the mutant did not show attenuation at weeks 2, 8, and 12 (data
not shown). It has been reported that isocitrate lyase is essential
for Salmonella persistence in mice during chronic infection but
dispensable for acute lethal infection (53). Similarly, isocitrate
lyase is dispensable in the acute phase of Mycobacterium tubercu-
losis infection in lung macrophages of mice but facilitates persis-
tence during the chronic phase (54). Accordingly, we repeated the
mouse infections and determined the number of BABaceA CFU
in spleens 16 and 24 weeks later. However, we did not find any
difference between this mutant and the parental strain (data not
shown). Therefore, even though we did not rule out the possibility
that the glyoxylate cycle plays a role under conditions different
from those tested in vitro, we concluded that this shunt is not
essential for B. abortus multiplication and persistence in the
laboratory models used. Since the PEP-glyoxylate pathway relies
on both AceA and PckA, this conclusion can be extended to this
cycle.
FIG 7 Trafficking of BAB-parental, BABppdK, and the virB mutant in macrophages and HeLa cells. (A) Confocal images of infected RAW 264.7 macrophages
and HeLa cells labeled with monoclonal antibodies to either calnexin (green) or LAMP-1 (blue) 24 h after infection (bacteria are immunostained in red). (B)
Percentage of calnexin-positive vacuoles of HeLa cells that contain bacteria at 24 and 48 h postinfection.
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DISCUSSION
B. abortus lacks the genes necessary for the metabolism of glycogen
and poly-beta-hydroxyalkanoates, the two C reserve materials
used by prokaryotes (55). Thus, these bacteria depend on nutri-
ents provided by the host to multiply intracellularly, and accord-
ingly, they need a supply of (at least) 6 C skeletons to carry out
gluconeogenesis. To investigate these possibilities, we deleted
ORFs that could encode enzymes of critical steps of gluconeogen-
esis, or of steps providing the necessary precursors. The genomic
characteristics of the ORFs analyzed and the phenotypes observed
in vitro support the hypothesis that they encode FBPases, a pyru-
vate phosphate dikinase, and a malic enzyme of B. abortus. More-
over, the analyses in cells show that the proteins coded for by ppdK
andmae become necessary once the replicative niche is reached, as
expected for metabolic mutants.
Since FBPases are essential for gluconeogenesis, the observa-
tion that growth in gluconeogenic media was not abolished in the
Fbp-GlpX double mutant is intriguing, and several hypotheses
can be considered to explain these results. The existence of a third
FBPase is the first and most obvious possibility. So far, five differ-
ent types of FBPases (I to V) in prokaryotes have been described
(56). Whereas FBPases of classes IV and V are restricted toArchaea
and their close hyperthermophilic Aquifex bacterial group, many
bacteria have dual combinations of class I (Fbp homologues), class
II (GlpX homologues), and class III FBPases (34, 56). However, a
genomic search for Bacillus subtilis YydE homologues (the proto-
type of class III FBPases [57]) in the Brucellaceae revealed only an
imperfect match (a hypothetical protein of 218 amino acids with a
32% identity with the 671 amino acids in YydE) in Ochrobactrum
anthropi and none in Brucella. This is in agreement with the fact
that no bacterial genome has been described as carrying a combi-
nation of classes I and III (34). Also, it has been reported that some
E. coli strains carry two class II FBPases (GlpX and YggF [56]), but
genomic analysis of all phosphatases inB. abortus failed to identify
clear candidates for any phosphatase close to GlpX and Fbp (see
Fig. S4 in the supplemental material). This genomic evidence and
the Fbp-GlpX reciprocal complementation (i.e., the fact that only
the double mutant shows a phenotype in vitro in the absence of
glycerol) suggest that these are the main and possibly the only
FBPases in B. abortus. An alternative to the third-FBPase hypoth-
esis is the existence of an atypical gluconeogenesis less efficient
than the classical one. Hypothetically, a fructose-6-P aldolase
could take part in gluconeogenesis. This has been described for E.
coli K-12, where ORF b0825 encodes an enzyme that catalyzes the
reversible conversion of fructose-6-P to dihydroxyacetone and
glyceraldehyde-3-P (58). This aldolase is different from that oper-
ating in the pentose-phosphate cycle, and its physiological role is
uncertain. However, the only homolog in B. abortus (ORF
BAB1_1813) is annotated as transaldolase, and in addition to the
fact that it should represent the enzyme of the pentose-phosphate
cycle, the identity (30%) is below the threshold considered to be
significant (59). Obviously, a rigorous analysis of these two hy-
potheses requires enzymatic analysis of doubly deficient cells. Fi-
nally, the significance of the mucoid aggregates produced by the
double FBPase mutant cannot be disregarded, since this pheno-
type suggests that the growth observed does not correspond to a
natural condition.
Although it should be borne in mind that enzymatic analyses
are necessary to reach definite conclusions, our results and those
of previous works with B. abortus 2308 offer insight into some
global models of the metabolism of these bacteria during intracel-
lular life in the host.
A first model (the gluconeogenic model) can be proposed on
the basis of the ability of B. abortus to grow in the defined medium
of Gerhardt and Wilson and on proteomic studies in macrophages
that suggest that B. abortus shifts to an amino acid-based metab-
FIG 8 Bacterial multiplication (top) and spleen weights (bottom) generated in BALB/c mice by BAB-parental and the mutants BABfbpglpX (A); BABpckA,
BABppdK, and BABpckAppdK (B); and BABmae (C). Each point is the mean	 standard deviation (n 5) of the log CFU or grams per spleen. Statistical
differences relative toBAB-parental were significant (P
 0.001) from week 4 onwards forBABppdK and from week 2 onwards forBABmae.BABpckAppdK
was also attenuated at weeks 8 and 12 (P
 0.001) (weeks 4 and 6 were not tested).
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olism in which the glutamate pool is increased (23). According to
this model, molecules like glycerol, lactate, or pyruvate and amino
acids channeled to oxaloacetate, keto-glutarate, or pyruvate are
the main substrates, and molecules of 6 and 5 C are derived from
the latter. In this regard, it is remarkable that dysfunction of two
major FBPases did not bring about any perceptible attenuation
either in cells or mice. Although the reduced growth of the
BABfbpglpx mutant in vitro precludes a clear-cut conclusion,
the contrasting in vivo and in vitro multiplication and the mucoid
phenotype of the double mutant in the minimal medium are more
consistent with models other than the gluconeogenic one. More-
over, two lines of evidence indicate that glucose (or closely related
hexoses) is available in the host. First, aB. abortus 2308 (andB. suis
1330) GluP (glucose/galactose transporter) mutant has been iden-
tified as attenuated in signature-tagged experiments (15, 20, 20).
Second, it was reported recently that the multiplication of B. abor-
tus in alternatively activated macrophages increases when the in-
tracellular glucose levels are artificially increased (60). Based on
these observations, an almost opposite model proposes a main
role for 6 C sugars in the replicative niche (and 5 C sugars if we
assume that the evidence obtained inB.melitensis also applies toB.
abortus; see the introduction). These sugars would provide triose-
phosphate through the pentose phosphate cycle and also serve as
precursors for biosynthesis of envelope polymers. This second
model, however, does not account for the attenuation observed
for the ppdK and mae mutants, which strongly suggests that mol-
ecules necessary for growth are derived from the TCA in vivo.
A third model proposes that there is a limited supply of 6 C
(and 5 C) sugars that is compensated for by glutamate, alanine,
and other amino acids. Those sugars would be used mostly or
exclusively for biosynthesis of envelope polymers and for the pen-
tose-phosphate cycle-dependent biosynthetic reactions. This
model is consistent with the results of this and previous works.
First, the different phenotype of the B. abortus double mutant
BABfbpglpx in vivo and in vitro is more consistent with the
hypothesis that classical gluconeogenesis is not extensively used in
vivo. In addition, the B. abortus 2308 gluP mutant identified in
signature-tagged mutagenesis studies is not clearly attenuated at 2
weeks postinfection and manifests its attenuation at a time (8
weeks) that corresponds to the chronic phase (20). This suggests
that the bacteria do not depend totally on hexoses for intracellular
biosynthetic processes and that this dependence is manifested at
late times, perhaps as the result of changes in the replicative vac-
uole (see below). Indeed, the infection experiments performed in
alternatively activated macrophages suggest that, although avail-
able, glucose is a limiting factor for B. abortus growth at least
during the chronic phase (60). Proteomic studies carried out with
B. abortus 2308 show that expression of two proteins of the dihy-
droxyacetone kinase complex (Dha) of the PEP-carbohydrate
phosphotransferase system (PTS) is reduced throughout infection
in macrophages (23). Although this has been interpreted to mean
that reduced PTS expression may be the result of a short supply of
sugars within the replicative niche, theBrucellaPTS lacks the sugar
permease unit and is likely to act as a regulatory system coordinat-
ing C and N metabolism (61). On the other hand, the signature-
tagged mutagenesis and proteomic studies show attenuation of
gltD (putatively encoding the small subunit of glutamate syn-
thase) mutant (20) and an increment of enzymes involved in in-
creasing the pool of glutamate (23) that is consistent with the
model. Finally, this third model accounts for the attenuation of
the ppdK and mae mutants and could also explain in part the
differences between the mutants in these two genes that were ob-
served in mice (Fig. 8). Since, according to the model, sugars are
used mostly to construct envelope polymers and for pentose-
phosphate cycle-derived precursors, additional molecules for bio-
synthesis must be derived from the TCA cycle. PpdK works to
produce PEP, which is used to synthesize phenylalanine, tyrosine,
tryptophan, glycerolipids, and other PEP-derived molecules. Mae
supplies pyruvate for PpdK in vivo, but TCA would not be the only
source of pyruvate. This is suggested by the fact that the mae mu-
tant was both delayed in reaching the chronic phase of infection
and present in lower numbers in the spleen during this phase,
which contrasts with the inability of the ppdK mutant to generate
chronic infections. Interestingly, it was recently shown that, when
provided with multiple carbon sources, Mycobacterium tuberculo-
sis differentially catabolizes each carbon source through the gly-
colytic, pentose phosphate, and/or TCA pathways to distinct met-
abolic fates, and it has been suggested that this ability reflects an
adaptation to pathogenicity (62). Indeed, such ability could also
be necessary for B. abortus to coordinately use the different sub-
strates proposed for this model.
Although the last model fits the experimental evidence, it is
obvious that it represents only a first approach to the situation in
natural hosts, because we cannot assume that the niche is static
during a chronic infection or uniform among different types of
cells. In the above-mentioned signature-tagged mutagenesis stud-
ies, Hong et al. (20) presented evidence for the hypothesis that
different sets of genes are required during the onset-acute phases
and the chronic steady phase. This study identified three putative
metabolic genes (gluP, glpD [see above], and gcvP) required dur-
ing the chronic phase but not markedly during the acute phase of
infection. Indeed, both the need for a functional ppdK for the
infection to progress during the acute phase and the different phe-
notype of mae add further support to the hypothesis that different
genes are required to different extents during the course of infec-
tion. Moreover, at least macrophages and trophoblastic cells have
been clearly associated with B. abortus infection in cattle (63), and
the physiological characteristics of these cells are different. Also,
different spleen cells become colonized at different times after
intraperitoneal inoculation of mice (64). Clearly, research is nec-
essary to investigate these aspects of the relationship between me-
tabolism and intracellular multiplication in B. abortus and in
other species of the genus.
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